Scienture Holdings/$SCNX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Scienture Holdings
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
Ticker
$SCNX
Sector
Primary listing
Employees
7
Headquarters
Website
SCNX Metrics
BasicAdvanced
$15m
-
-$2.70
-
-
Price and volume
Market cap
$15m
52-week high
$2.60
52-week low
$0.24
Average daily volume
689k
Financial strength
Current ratio
2.894
Quick ratio
2.703
Total debt to equity
0.034
Interest coverage (TTM)
-3.98%
Profitability
EBITDA (TTM)
-15.789
Gross margin (TTM)
76.80%
Net profit margin (TTM)
-9,618.03%
Operating margin (TTM)
-3,763.86%
Effective tax rate (TTM)
4.59%
Revenue per employee (TTM)
$60,000
Management effectiveness
Return on assets (TTM)
-10.74%
Return on equity (TTM)
-55.65%
Valuation
Price to revenue (TTM)
13.232
Price to book
0.22
Price to tangible book (TTM)
-17.73
Price to free cash flow (TTM)
-0.427
Free cash flow yield (TTM)
-234.29%
Free cash flow per share (TTM)
-0.872
Growth
Revenue change (TTM)
215.87%
Earnings per share change (TTM)
-200.88%
3-year revenue growth (CAGR)
12.89%
3-year earnings per share growth (CAGR)
53.93%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Scienture Holdings stock?
Scienture Holdings (SCNX) has a market cap of $15M as of May 01, 2026.
What is the P/E ratio for Scienture Holdings stock?
The price to earnings (P/E) ratio for Scienture Holdings (SCNX) stock is 0 as of May 01, 2026.
Does Scienture Holdings stock pay dividends?
No, Scienture Holdings (SCNX) stock does not pay dividends to its shareholders as of May 01, 2026.
When is the next Scienture Holdings dividend payment date?
Scienture Holdings (SCNX) stock does not pay dividends to its shareholders.
What is the beta indicator for Scienture Holdings?
Scienture Holdings (SCNX) does not currently have a Beta indicator.